Showing 1 to 12 of 35 results
UK Campaign Demands Menopause Support in Cancer Care Plans
A UK charity, Menopause and Cancer, reports that 90% of 1,200 surveyed cancer patients lacked menopause support in their treatment plans, prompting calls for improved healthcare professional training and better access to therapies.
UK Campaign Demands Menopause Support in Cancer Care Plans
A UK charity, Menopause and Cancer, reports that 90% of 1,200 surveyed cancer patients lacked menopause support in their treatment plans, prompting calls for improved healthcare professional training and better access to therapies.
Progress
24% Bias Score
Menopause Misconceptions: Beyond Hot Flashes
This article dispels common misconceptions about menopause, highlighting the wide range of symptoms, the role of hormone therapy, and the importance of addressing the issue openly.
Menopause Misconceptions: Beyond Hot Flashes
This article dispels common misconceptions about menopause, highlighting the wide range of symptoms, the role of hormone therapy, and the importance of addressing the issue openly.
Progress
12% Bias Score
Underdiagnosed GSM Impacts Millions of Postmenopausal Women
Affecting 27-84% of postmenopausal women, Genitourinary Syndrome of Menopause (GSM) causes vaginal dryness, pain during intercourse, and urinary issues, often misdiagnosed as urinary tract infections; effective treatments are available, including hormone therapy and vaginal moisturizers.
Underdiagnosed GSM Impacts Millions of Postmenopausal Women
Affecting 27-84% of postmenopausal women, Genitourinary Syndrome of Menopause (GSM) causes vaginal dryness, pain during intercourse, and urinary issues, often misdiagnosed as urinary tract infections; effective treatments are available, including hormone therapy and vaginal moisturizers.
Progress
24% Bias Score
Menopause Misdiagnosis: Vasomotor Symptoms Highlight Diagnostic Gaps
A study in The Lancet Diabetes & Endocrinology shows that 40% of women without menstruation experience moderate to severe vasomotor symptoms during menopause, highlighting the need for a broader diagnostic approach beyond menstrual cycle changes.
Menopause Misdiagnosis: Vasomotor Symptoms Highlight Diagnostic Gaps
A study in The Lancet Diabetes & Endocrinology shows that 40% of women without menstruation experience moderate to severe vasomotor symptoms during menopause, highlighting the need for a broader diagnostic approach beyond menstrual cycle changes.
Progress
28% Bias Score
FDA Panel Urges Removal of Black Box Warnings for Low-Dose Vaginal Estrogen
An FDA panel recently recommended removing black box warnings from low-dose vaginal estrogen treatments due to concerns that they overstate risks and deter women from using beneficial menopause medications; this decision follows decades of evolving understanding of HRT safety and efficacy.
FDA Panel Urges Removal of Black Box Warnings for Low-Dose Vaginal Estrogen
An FDA panel recently recommended removing black box warnings from low-dose vaginal estrogen treatments due to concerns that they overstate risks and deter women from using beneficial menopause medications; this decision follows decades of evolving understanding of HRT safety and efficacy.
Progress
48% Bias Score
France to Revise Hormone Replacement Therapy Guidelines in 2026
Hormone Replacement Therapy (HRT), used to treat menopausal symptoms, faced controversy after a 2002 US study linked it to increased health risks; however, this study's methodology is now debated, and France is revising its HRT guidelines in 2026 to reflect updated research and address past misconce...
France to Revise Hormone Replacement Therapy Guidelines in 2026
Hormone Replacement Therapy (HRT), used to treat menopausal symptoms, faced controversy after a 2002 US study linked it to increased health risks; however, this study's methodology is now debated, and France is revising its HRT guidelines in 2026 to reflect updated research and address past misconce...
Progress
36% Bias Score
FDA Weighs Removing Menopause Hormone Therapy Warnings Amidst New Research
The FDA is considering removing health warnings from some menopause hormone therapy treatments following new research that suggests previous safety concerns were overstated, prompting debate among experts.
FDA Weighs Removing Menopause Hormone Therapy Warnings Amidst New Research
The FDA is considering removing health warnings from some menopause hormone therapy treatments following new research that suggests previous safety concerns were overstated, prompting debate among experts.
Progress
20% Bias Score
Over-the-Counter Menopause Hormone Tests Deemed Clinically Useless
Senior doctors warn that readily available, expensive hormone tests for menopause are misleading, medically unnecessary, and risk undermining women's healthcare, urging reliance on symptom-based diagnosis instead.
Over-the-Counter Menopause Hormone Tests Deemed Clinically Useless
Senior doctors warn that readily available, expensive hormone tests for menopause are misleading, medically unnecessary, and risk undermining women's healthcare, urging reliance on symptom-based diagnosis instead.
Progress
48% Bias Score
FDA Panel Recommends Removing Black Box Warning from Some Menopause Treatments
The FDA may remove the black box warning on estrogen-containing menopause treatments following an expert panel's recommendation, based on updated analyses suggesting that hormone therapy may not increase risks as previously thought, particularly when initiated before age 60 or within 10 years of men...
FDA Panel Recommends Removing Black Box Warning from Some Menopause Treatments
The FDA may remove the black box warning on estrogen-containing menopause treatments following an expert panel's recommendation, based on updated analyses suggesting that hormone therapy may not increase risks as previously thought, particularly when initiated before age 60 or within 10 years of men...
Progress
36% Bias Score
The M Factor Film's Global Impact on Menopause Awareness and Care
The M Factor film, a short documentary on menopause, has been screened globally, significantly impacting public understanding, clinical care, and policy, resulting in increased doctor consultations and improved clinician knowledge.
The M Factor Film's Global Impact on Menopause Awareness and Care
The M Factor film, a short documentary on menopause, has been screened globally, significantly impacting public understanding, clinical care, and policy, resulting in increased doctor consultations and improved clinician knowledge.
Progress
52% Bias Score
The Assassin": Menopausal Hitwoman Returns
Keeley Hawes stars in "The Assassin" as Julie, a retired hitwoman forced back into action when her handler disappears, leading her on a thrilling chase involving her son's unexpected questions about his father and a complex web of international intrigue.
The Assassin": Menopausal Hitwoman Returns
Keeley Hawes stars in "The Assassin" as Julie, a retired hitwoman forced back into action when her handler disappears, leading her on a thrilling chase involving her son's unexpected questions about his father and a complex web of international intrigue.
Progress
56% Bias Score
Early Menopause in South Asia: A Decade of Difference
South Asian women experience menopause a decade earlier than the global average (45-55 years), due to genetics, body composition, Vitamin D deficiency, and cultural pressures to bear children early, resulting in a lack of awareness and access to treatments like HRT.
Early Menopause in South Asia: A Decade of Difference
South Asian women experience menopause a decade earlier than the global average (45-55 years), due to genetics, body composition, Vitamin D deficiency, and cultural pressures to bear children early, resulting in a lack of awareness and access to treatments like HRT.
Progress
32% Bias Score
Showing 1 to 12 of 35 results